Therapeutic versus prophylactic anticoagulation in patients with COVID-19: a meta-analysis of randomised controlled trials

Back

ACVC Premium Access

Therapeutic versus prophylactic anticoagulation in patients with COVID-19: a meta-analysis of randomised controlled trials

Session: COVID-19 - here to stay?

Topic: Anticoagulants

Speaker: Professor R. Sakurai (Tokyo, JP)

Event: ESC Acute CardioVascular Care 2022

Congress Presentation

Add to my library

About the speaker

Professor Ryota Sakurai

Graduate School of Public Health, International University of Health and Welfare, Tokyo (Japan)

0 follower

5 more presentations in this session

Short term impact of COVID-19 pneumonia in patients with reduced left ventricular ejection fraction (LVEF)

Speaker: Doctor S. THANGASAMI (Chennai, IN)

New-onset atrial fibrillation predicts poor prognosis in critically ill COVID-19 patients

Speaker: Doctor V. Lopes (Coimbra, PT)

Chest pain post anti-Covid-19 vaccination with mRNA BNT162b2 vaccine : the experience of a secondary hospital

Speaker: Doctor M. Stratinaki (Heraklion, GR)

Elevation in troponin associated with COVID-19 is associated with an adverse long-term outcome

Speaker: Doctor A. Deshpande (London, GB)

Recurrent myocardial injury is a strong predictor of ICU mortality in COVID-19.

Speaker: Doctor F. De Roeck (Edegem, BE)

Access the full session

COVID-19 - here to stay?

Speakers: Professor R. Sakurai, Doctor S. THANGASAMI, Doctor V. Lopes, Doctor M. Stratinaki, Doctor A. Deshpande...

Access

About the event

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources